Total planned funding: $173,013,232
Allocations
Countries/Regions
India | $173,013,232 |
Organizational Types
Unknown | $77,536,937 |
NGO | $44,540,564 |
Own Agency | $27,639,434 |
University | $9,840,217 |
Private Contractor | $4,098,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,856,808 |
FBO | $2,200,000 |
Host Country Government Agency | $1,201,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $75,273,686 |
Prevention | $38,597,605 |
Management and Operations | $21,576,440 |
Care | $17,542,527 |
Testing | $7,973,570 |
Treatment | $7,621,612 |
Budget Codes
OHSS: Health Systems Strengthening | $44,509,210 |
HVSI: Strategic Information | $23,469,647 |
HVMS: Management and Operations | $21,576,440 |
HVOP: Sexual Prevention: Other Sexual Prevention | $19,897,506 |
HBHC: Care: Adult Care and Support | $10,844,101 |
HVCT: Testing: HIV Testing and Counseling | $7,973,570 |
HLAB: Laboratory Infrastructure | $7,294,829 |
HTXS: Treatment: Adult Treatment | $6,993,211 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,417,476 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,870,783 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,542,004 |
HKID: Care: Orphans and Vulnerable Children | $3,412,600 |
HVTB: Care: TB/HIV | $2,893,080 |
HMBL: Biomedical Prevention: Blood Safety | $1,869,836 |
PDTX: Treatment: Pediatric Treatment | $604,924 |
PDCS: Care: Pediatric Care and Support | $392,746 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$77,536,937
Countries/Regions
USG Aggregated Agencies:
$21,646,535
Countries/Regions
FHI 360:
$19,765,311
Countries/Regions
Voluntary Health Services:
$6,260,000
Countries/Regions